Allies of Donald Trump have painted themselves into a cognitive corner. President Biden is unfit for office, they argue, because he is so old, and his mental abilities have deteriorated markedly. But then Biden will, say, deliver a State of the Union address in which he is energetic and pointed for more than an hour.
Washington
Analysis | No, Biden won’t be on performance-enhancing drugs for the debate
So they modify their claim: Biden is addled and wandering, except when he is given some sort of medication, perhaps a stimulant, that reverses that effect. And here we are, with Trump and those seeking his reelection to the White House demanding that Biden submit to some sort of drug test before this week’s first presidential debate, purportedly in effort to sniff out this theoretical drug.
Experts who spoke with The Washington Post, though, confirm that no such medicine exists.
At the outset, we should recognize that this claim is generally not offered seriously. It is, instead, an effort to escape the aforementioned contradiction, a way to hold both that Biden is incapable of serving as president and yet, unquestionably at times, not demonstrating any such impairment. What’s more, the demand that Biden undergo a drug test is itself not serious. It is, instead, meant to create a condition that allows Trump and his allies to continue to claim that any strong performance from Biden is a function of medication. The result is win-win for Trump, who can blame any loss on this wonder drug.
If you haven’t been paying close attention to the debate (such as it is) over this idea, consider a snippet of conversation that aired on Fox Business on Tuesday morning.
Host Maria Bartiromo — no stranger to conspiratorial argumentation — hosted Rep. Eric Burlison (R-Mo.) where she offered an observation made by Rep. Ronny Jackson (R-Tex.).
“Jackson says Biden will have been at Camp David for a full week before the debate,” Bartiromo said, “and that they’re probably experimenting with getting doses right. Giving him medicine ahead of the debate.”
Burlison agreed that this was possible, though he offered that it might be more innocuous than medication. Perhaps, he said, Biden’s team is “jack[ing] him up on Mountain Dew.”
Jackson, you will recall, was Trump’s personal doctor while Trump was in the White House. He is not an expert on cognition or cognition-related illnesses, though he is familiar with drug prescription.
“Nothing like that exists,” Thomas Wisniewski, director of the NYU Langone Alzheimer’s Disease Research Center, told The Washington Post by phone. “There are no medications or stimulants that can reverse a dementing process transiently.”
“All of those sorts of things can perhaps make an individual more alert, but quite often that can just exacerbate their confusion, as well,” he added. “They can be more stimulated, but they are not going to be behaving in a more cogent or normal fashion as a result of being stimulated by anything. Very often it’s the reverse.”
Adam Brickman, associate professor of neuropsychology at Columbia University Irving Medical Center, concurred with that assessment.
“I’m not aware of any medications that would reverse or mask cognitive decline,” Brickman said. What’s more, he noted that “the association between energy and cognition is a very weak one. In other words, someone could have low energy but totally intact cognition and vice versa.”
Both doctors noted that such a medication would be of enormous benefit. Reversing cognitive decline, after all, would mean turning back the damage done from diseases that impair cognition in the first place. It would be akin not just to treating the pain of a broken bone but, instead, to directly healing the break itself. Sadly, no such drug for cognition exists.
Again, the argument that Biden is or could be receiving targeted treatment to improve his mental state fails multiple logical tests. Why, for example, would he not simply take this medication all the time? Why would he need to retest his dosage for a debate after giving a lengthy State of the Union address? The answer is that there is no good answer, that the intent of the allegations is simply to maintain the political argument that Biden is mentally deficient even in the face of his performing above expectations in a debate.
Not that that argument is itself well-grounded, as Brickman noted.
“It’s not possible to conclude or to determine whether someone has subtle cognitive change without doing a true clinical evaluation,” he said. “So to judge whether there’s an underlying disease or neurodegenerative condition based on public speeches or interactions that are captured by the press is irresponsible.”
Wisniewski offered a more succinct dismissal of the claims being made by Trumpworld.
“It’s spurious,” he said. “It’s nonsensical.”
In other words, if Biden fares better in the debate this week, it’s not because of a secret Camp David drug-dosing regimen that enabled the administration to mask Biden’s physical degeneration. It’s because Biden out-debated the guy who won’t accept that that’s possible.
Washington
Man charged with shooting co-worker in Washington Heights
A 26-year-old man had an argument with a co-worker before allegedly fatally shooting the colleague in Washington Heights, prosecutors said Friday.
Bobby Martin, who was charged with first-degree murder Thursday, made his first appearance Friday in Cook County court.
Martin, is accused of killing his co-worker, Antoine Alexander, 32, in a parking lot at 9411 S Ashland Ave about 3:30 p.m. on Tuesday, according to Chicago police.
Prosecutors said Martin and Alexander worked together at an armed security company and got into a verbal altercation inside the guard shack on Tuesday afternoon. During the altercation, prosecutors said Alexander removed his bullet proof vest and threw it to the ground. A witness, another co-worker, then told the defendant and the victim to take the altercation outside.
After stepping outside, the defendant pulled his firearm and fired one shot into the victims abdomen, prosecutors said. The victim’s firearm was holstered at the time of the argument and the shooting. The defendant fled the scene and came into contact with another co-worker, whom he told that he had just shot Alexander.
Alexander was then taken to Advocate Christ Medical Center in Oak Lawn, where he was pronounced dead.
Martin was arrested by authorities three blocks from his home approximately 20 minutes after the shooting, prosecutors said.
Martin was detained and will appear in court again on March 17, authorities said.
.
Washington
Washington Spirit goalkeeper Aubrey Kingsbury announces she’s pregnant
Trinity Rodman signs record deal with Washington Spirit
USWNT forward Trinity Rodman signed a three-year deal with the NWSL’s Washington Spirit. The deal makes Rodman the highest-paid female footballer in the world.
unbranded – Sport
Washington Spirit goalkeeper Aubrey Kingsbury has announced that she and her husband Matt are expecting a baby in July.
The couple made the announcement in a video on the Spirit’s social media channels, holding a baby goalkeeper jersey on the pitch at Audi Field.
Kingsbury becomes the most recent Spirit star to go on maternity leave, following defender Casey Krueger, midfielder Andi Sullivan and forward Ashley Hatch.
Sullivan gave birth to daughter Millie in July, while Hatch welcomed her son Leo in January.
Krueger announced she was pregnant with her second child in October.
Kingsbury has served as the Spirit’s starting goalkeeper since 2018, and has been named the NWSL Goalkeeper of the Year twice (2019 and 2021).
The 34-year-old has two caps with the U.S. women’s national team, and was named to the 2023 World Cup roster.
The club captain will leave a major void for the Spirit, who have finished as NWSL runner-up in back-to-back seasons.
Sandy MacIver and Kaylie Collins are expected to compete for the starting role while Kingsbury is on maternity leave.
The Spirit kick off their 2026 campaign on March 13 against the Portland Thorns.
Washington
Washington state board awards Yakima $985,600 loan for Sixth Avenue project design
YAKIMA, Wash. — Yakima could soon take a major step toward redesigning Sixth Avenue after the Washington State Public Works Board awarded the city a $985,600 loan.
The loan was approved for the design engineering phase of the Sixth Avenue project. The funding can also be used along Sixth Avenue for utility replacement and updated ADA use.
The Yakima City Council must decide whether to accept the award. If the council accepts it, the city’s engineering work will move forward with the design of Sixth Avenue.
The cost of installing trolley lines is excluded from the plan. The historic trolleys would need to raise the funds required to add trolley lines.
The award is scheduled to be discussed during next week’s City Council meeting.
-
World2 days agoExclusive: DeepSeek withholds latest AI model from US chipmakers including Nvidia, sources say
-
Massachusetts3 days agoMother and daughter injured in Taunton house explosion
-
Montana1 week ago2026 MHSA Montana Wrestling State Championship Brackets And Results – FloWrestling
-
Louisiana5 days agoWildfire near Gum Swamp Road in Livingston Parish now under control; more than 200 acres burned
-
Denver, CO3 days ago10 acres charred, 5 injured in Thornton grass fire, evacuation orders lifted
-
Technology1 week agoYouTube TV billing scam emails are hitting inboxes
-
Technology7 days agoStellantis is in a crisis of its own making
-
Politics7 days agoOpenAI didn’t contact police despite employees flagging mass shooter’s concerning chatbot interactions: REPORT